SCHEMBL24322374

SCHEMBL24322374

CC1CCN(CC[C@@H]2CCCCN2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.43
CARM1 Q86X55 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
PRMT1 Q99873 1/20 0.43
PRMT8 Q9NR22 1/20 0.43
HRH3 Q9Y5N1 3/20 0.40
SIGMAR1 Q99720 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
HTR1A P08908 2/20 0.37
HTR2A P28223 2/20 0.37
KCNH2 Q12809 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
MLNR O43193 1/20 0.37
ABCB11 O95342 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24322571 1.00 ACHE (0.43) ACHECARM1PRMT6PRMT1PRMT8
SCHEMBL4300726 0.95 CARM1 (0.44) ACHECARM1PRMT6PRMT1PRMT8
SCHEMBL24322555 0.95 CARM1 (0.44) ACHECARM1PRMT6PRMT1PRMT8
SCHEMBL4300723 0.95 CARM1 (0.44) ACHECARM1PRMT6PRMT1PRMT8
SCHEMBL8333360 0.85 CYP1A2 (0.46) HRH3SIGMAR1CYP1A2CYP2D6HTR1A
SCHEMBL18183309 0.84 HTR1A (0.40) HRH3SIGMAR1CYP1A2CYP2D6HTR1A
SCHEMBL7961057 0.83 CYP1A2 (0.48) HRH3SIGMAR1CYP1A2CYP2D6HTR1A
SCHEMBL4454573 0.83 CYP1A2 (0.48) HRH3SIGMAR1CYP1A2CYP2D6HTR1A
SCHEMBL5683177 0.83 CYP1A2 (0.48) HRH3SIGMAR1CYP1A2CYP2D6HTR1A
SCHEMBL4376304 0.82 CYP2D6 (0.37) HRH3SIGMAR1CYP1A2CYP2D6HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220122691-A1 HtrA Inhibitors and CagA Inhibitors and Use Thereof Psomagen Inc. (US) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220122691-A1 HtrA Inhibitors and CagA Inhibitors and Use Thereof HTRA1, GIPR, HPN ACHE 4649/4885CARM1 4394/4885PRMT6 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.